Latest filing published 18 Jul 2024 for American Oncology Network, Inc.. Read the official filing
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of David Afshar across 2 companies, led by Aveanna Healthcare Holdings, Inc. and American Oncology Network, Inc. Over a trading history stretching from 30 April 2021 to 16 July 2024, the count stands at 10 filings.
No open-market sale appears; the market trades are 6 purchases worth €190k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants.
In size, the median ticket on the buying side is €30k. Clusters matter here: 1 out of 6 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
Most recently, on 18 July 2024, the filings show a share grant in American Oncology Network, Inc. The latest purchase dates back some time: it was published 1,516 days ago, on 24 August 2022. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations